<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04586400</url>
  </required_header>
  <id_info>
    <org_study_id>201706062</org_study_id>
    <nct_id>NCT04586400</nct_id>
  </id_info>
  <brief_title>Chromosome 9 P Minus Syndrome</brief_title>
  <official_title>Genotype-Phenotype Correlation in Patients With Chromosome 9 P Minus Syndrome</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Washington University School of Medicine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Washington University School of Medicine</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Patients with deletion of chromosome 9 P are rare (~200 in the medical literature) and have a&#xD;
      diverse set of phenotypic characteristics. We propose using state of the art genome&#xD;
      sequencing methods to define the location and size of the deleted portion of chromosome 9 P&#xD;
      as well as the genetic background in affected patients (whole genome sequencing) and&#xD;
      correlate the genes in the deleted portion of chromosome 9 P with specific phenotypic&#xD;
      characteristics of each patient assessed by a an updated, more detailed questionnaire.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 27, 2017</start_date>
  <completion_date type="Anticipated">June 2022</completion_date>
  <primary_completion_date type="Anticipated">June 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Genotypic and Phenotypic Correlation</measure>
    <time_frame>As enrollment increases the team hopes to have preliminary results by 2022</time_frame>
    <description>By use of demographic and genetic material we hope to gain a better understanding between the deletion on the short arm of the 9th chromosome and the features presented.</description>
  </primary_outcome>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Chromosome 9P Deletion Syndrome</condition>
  <condition>9p Minus Syndrome</condition>
  <condition>Alfi Syndrome</condition>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Saliva, blood or skin biopsy samples may be obtained in this study.&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        The Principal Investigator and members of the study team in collaboration with the 9 P&#xD;
        Minus Network (http://9pminus.org/), Unique (https://www.rarechromo.org/), and other&#xD;
        members of the 9 P Minus community will identify candidate participants with 9 P minus&#xD;
        syndrome.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Having 9P minus syndrome&#xD;
&#xD;
          -  Parents and siblings of affected individuals may also be included to determine&#xD;
             contribution of genetic background to phenotypic characteristics&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  No exclusion criteria for either affected individuals or their parents or siblings.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>F. S Cole, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Washington University School of Medicine</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>F. S. Cole, M.D.</last_name>
    <phone>314-454-6183</phone>
    <email>fcole@wustl.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Victoria E Tate, B.S.</last_name>
    <phone>3142861547</phone>
    <email>victoriatate@wustl.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Washington University School of Medicine</name>
      <address>
        <city>Saint Louis</city>
        <state>Missouri</state>
        <zip>63110</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Victoria E Tate, B.S.</last_name>
      <phone>314-286-1547</phone>
      <email>victoriatate@wustl.edu</email>
    </contact>
    <investigator>
      <last_name>F. S. Cole, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2020</verification_date>
  <study_first_submitted>October 6, 2020</study_first_submitted>
  <study_first_submitted_qc>October 6, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">October 14, 2020</study_first_posted>
  <last_update_submitted>October 6, 2020</last_update_submitted>
  <last_update_submitted_qc>October 6, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">October 14, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Syndrome</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>The study was created to have a better understanding of 9P minus syndrome. The team will educate participants regarding their genetic testing but this is not intended to influence medical decisions.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

